Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience.

ABSTRACT:

Background

The NCCN Guidelines for Survivorship recommend dedicated sleep assessment. Reported insomnia prevalence in the general Irish population is 6% to 15%. Reported insomnia prevalence internationally among new/recently diagnosed patients with cancer varies from 30.9% to 54.3%. Insomnia prevalence has not been previously quantified in an Irish oncology cohort.

Methods

A 40-item questionnaire was prospectively administered to ambulatory patients with cancer aged ≥18 years. Prespecified criteria to define insomnia syndrome combined those of the International Classification of Sleep Disorders, version 1, and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The Hospital Anxiety and Depression Scale-Depression/Anxiety (HADS-D/A) was used to

SUBMITTER: Harrold EC 

PROVIDER: S-EPMC9337980 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature